Recent advances in drug delivery systems for targeting brain tumors

Brain tumor accounts for about 1.6% of incidence and 2.5% of mortality of all tumors, and the median survival for brain tumor patients is only about 20 months. The treatment for brain tumor still faces many challenges, such as the blood-brain barrier (BBB), blood-brain tumor barrier (BBTB), the over...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yi, Yue, Ping, Peng, Yao, Sun, Yuanyuan, Chen, Xing, Zhao, Ze, Han, Bingjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828736/
https://www.ncbi.nlm.nih.gov/pubmed/36597214
http://dx.doi.org/10.1080/10717544.2022.2154409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828736/
https://www.ncbi.nlm.nih.gov/pubmed/36597214
http://dx.doi.org/10.1080/10717544.2022.2154409

Ejemplares similares